nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—obesity	0.439	1	CbGaD
Auranofin—PRDX5—hindbrain—obesity	0.0154	0.126	CbGeAlD
Auranofin—PRDX5—islet of Langerhans—obesity	0.00999	0.0814	CbGeAlD
Auranofin—PRDX5—respiratory system—obesity	0.00943	0.0769	CbGeAlD
Auranofin—PRDX5—adrenal cortex—obesity	0.00792	0.0645	CbGeAlD
Auranofin—PRDX5—cardiovascular system—obesity	0.00722	0.0589	CbGeAlD
Auranofin—PRDX5—pituitary gland—obesity	0.0064	0.0522	CbGeAlD
Auranofin—PRDX5—adipose tissue—obesity	0.00637	0.0519	CbGeAlD
Auranofin—PRDX5—digestive system—obesity	0.006	0.0489	CbGeAlD
Auranofin—PRDX5—adrenal gland—obesity	0.00571	0.0466	CbGeAlD
Auranofin—IKBKB—respiratory system—obesity	0.00559	0.0455	CbGeAlD
Auranofin—ALB—gall bladder—obesity	0.00527	0.0429	CbGeAlD
Auranofin—PRDX5—endocrine gland—obesity	0.00495	0.0404	CbGeAlD
Auranofin—PRDX5—liver—obesity	0.00447	0.0364	CbGeAlD
Auranofin—IKBKB—cardiovascular system—obesity	0.00428	0.0349	CbGeAlD
Auranofin—Aplastic anaemia—Cimetidine—obesity	0.00389	0.0205	CcSEcCtD
Auranofin—IKBKB—pituitary gland—obesity	0.00379	0.0309	CbGeAlD
Auranofin—IKBKB—adipose tissue—obesity	0.00377	0.0308	CbGeAlD
Auranofin—IKBKB—digestive system—obesity	0.00355	0.029	CbGeAlD
Auranofin—Loose stools—Bupropion—obesity	0.00349	0.0184	CcSEcCtD
Auranofin—IKBKB—adrenal gland—obesity	0.00338	0.0276	CbGeAlD
Auranofin—Dermatitis exfoliative—Cimetidine—obesity	0.00319	0.0168	CcSEcCtD
Auranofin—IKBKB—endocrine gland—obesity	0.00293	0.0239	CbGeAlD
Auranofin—Gingivitis—Sibutramine—obesity	0.00282	0.0149	CcSEcCtD
Auranofin—IKBKB—liver—obesity	0.00265	0.0216	CbGeAlD
Auranofin—Pancytopenia—Diethylpropion—obesity	0.0026	0.0137	CcSEcCtD
Auranofin—Pancytopenia—Cimetidine—obesity	0.00247	0.013	CcSEcCtD
Auranofin—Gingivitis—Bupropion—obesity	0.00246	0.013	CcSEcCtD
Auranofin—Neutropenia—Cimetidine—obesity	0.00243	0.0128	CcSEcCtD
Auranofin—Glossitis—Sibutramine—obesity	0.0024	0.0127	CcSEcCtD
Auranofin—Anorexia—Benzphetamine—obesity	0.00229	0.012	CcSEcCtD
Auranofin—Agranulocytosis—Diethylpropion—obesity	0.00228	0.012	CcSEcCtD
Auranofin—Dyspepsia—Methamphetamine—obesity	0.00219	0.0115	CcSEcCtD
Auranofin—Agranulocytosis—Cimetidine—obesity	0.00217	0.0114	CcSEcCtD
Auranofin—Constipation—Methamphetamine—obesity	0.00213	0.0112	CcSEcCtD
Auranofin—Dyspepsia—Benzphetamine—obesity	0.00211	0.0111	CcSEcCtD
Auranofin—Glossitis—Bupropion—obesity	0.0021	0.011	CcSEcCtD
Auranofin—Decreased appetite—Benzphetamine—obesity	0.00209	0.011	CcSEcCtD
Auranofin—Anorexia—Phendimetrazine—obesity	0.00208	0.011	CcSEcCtD
Auranofin—Hepatic enzyme increased—Bupropion—obesity	0.00204	0.0108	CcSEcCtD
Auranofin—Urticaria—Methamphetamine—obesity	0.00198	0.0104	CcSEcCtD
Auranofin—ALB—adrenal gland—obesity	0.00198	0.0161	CbGeAlD
Auranofin—Alopecia—Diethylpropion—obesity	0.00193	0.0102	CcSEcCtD
Auranofin—Urticaria—Benzphetamine—obesity	0.00191	0.01	CcSEcCtD
Auranofin—Decreased appetite—Phendimetrazine—obesity	0.0019	0.01	CcSEcCtD
Auranofin—Constipation—Phendimetrazine—obesity	0.00187	0.00985	CcSEcCtD
Auranofin—Alopecia—Cimetidine—obesity	0.00184	0.00969	CcSEcCtD
Auranofin—Flatulence—Cimetidine—obesity	0.00179	0.00941	CcSEcCtD
Auranofin—Abdominal pain—Phendimetrazine—obesity	0.00173	0.0091	CcSEcCtD
Auranofin—Leukopenia—Diethylpropion—obesity	0.00171	0.00898	CcSEcCtD
Auranofin—Diarrhoea—Methamphetamine—obesity	0.0017	0.00897	CcSEcCtD
Auranofin—Diarrhoea—Benzphetamine—obesity	0.00164	0.00865	CcSEcCtD
Auranofin—Leukopenia—Cimetidine—obesity	0.00162	0.00855	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Sibutramine—obesity	0.00161	0.00847	CcSEcCtD
Auranofin—Constipation—Phenylpropanolamine—obesity	0.0016	0.00841	CcSEcCtD
Auranofin—Dyspepsia—Phentermine—obesity	0.00157	0.00829	CcSEcCtD
Auranofin—Gingivitis—Topiramate—obesity	0.00157	0.00826	CcSEcCtD
Auranofin—ALB—liver—obesity	0.00154	0.0126	CbGeAlD
Auranofin—Constipation—Phentermine—obesity	0.00153	0.00805	CcSEcCtD
Auranofin—Diarrhoea—Phendimetrazine—obesity	0.0015	0.00788	CcSEcCtD
Auranofin—Dermatitis exfoliative—Bupropion—obesity	0.00149	0.00783	CcSEcCtD
Auranofin—Thrombocytopenia—Cimetidine—obesity	0.00145	0.00763	CcSEcCtD
Auranofin—Nausea—Benzphetamine—obesity	0.00143	0.00751	CcSEcCtD
Auranofin—Urticaria—Phentermine—obesity	0.00142	0.00748	CcSEcCtD
Auranofin—Abdominal pain—Phentermine—obesity	0.00141	0.00744	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Bupropion—obesity	0.0014	0.00739	CcSEcCtD
Auranofin—Dysphagia—Sibutramine—obesity	0.00139	0.00732	CcSEcCtD
Auranofin—Eosinophilia—Sibutramine—obesity	0.00138	0.00725	CcSEcCtD
Auranofin—Dyspepsia—Diethylpropion—obesity	0.00137	0.00721	CcSEcCtD
Auranofin—Glossitis—Topiramate—obesity	0.00134	0.00703	CcSEcCtD
Auranofin—Constipation—Diethylpropion—obesity	0.00133	0.007	CcSEcCtD
Auranofin—Hepatic enzyme increased—Topiramate—obesity	0.0013	0.00685	CcSEcCtD
Auranofin—Nausea—Phendimetrazine—obesity	0.0013	0.00684	CcSEcCtD
Auranofin—Constipation—Cimetidine—obesity	0.00127	0.00666	CcSEcCtD
Auranofin—Neuropathy peripheral—Orlistat—obesity	0.00126	0.00661	CcSEcCtD
Auranofin—Urticaria—Diethylpropion—obesity	0.00124	0.00651	CcSEcCtD
Auranofin—Diarrhoea—Phentermine—obesity	0.00122	0.00644	CcSEcCtD
Auranofin—Neuropathy peripheral—Sibutramine—obesity	0.00122	0.0064	CcSEcCtD
Auranofin—Dysphagia—Bupropion—obesity	0.00121	0.00638	CcSEcCtD
Auranofin—Stomatitis—Sibutramine—obesity	0.00121	0.00636	CcSEcCtD
Auranofin—Conjunctivitis—Sibutramine—obesity	0.00121	0.00635	CcSEcCtD
Auranofin—Melaena—Topiramate—obesity	0.0012	0.00633	CcSEcCtD
Auranofin—Vomiting—Phenylpropanolamine—obesity	0.00119	0.00626	CcSEcCtD
Auranofin—Haematuria—Sibutramine—obesity	0.00118	0.00623	CcSEcCtD
Auranofin—Rash—Phenylpropanolamine—obesity	0.00118	0.0062	CcSEcCtD
Auranofin—Dermatitis—Phenylpropanolamine—obesity	0.00118	0.0062	CcSEcCtD
Auranofin—Pancytopenia—Bupropion—obesity	0.00115	0.00606	CcSEcCtD
Auranofin—Vomiting—Phentermine—obesity	0.00114	0.00599	CcSEcCtD
Auranofin—Rash—Phentermine—obesity	0.00113	0.00594	CcSEcCtD
Auranofin—Dermatitis—Phentermine—obesity	0.00113	0.00593	CcSEcCtD
Auranofin—Nausea—Phenylpropanolamine—obesity	0.00111	0.00584	CcSEcCtD
Auranofin—Weight decreased—Bupropion—obesity	0.0011	0.00578	CcSEcCtD
Auranofin—Visual impairment—Sibutramine—obesity	0.00107	0.00565	CcSEcCtD
Auranofin—Diarrhoea—Diethylpropion—obesity	0.00106	0.0056	CcSEcCtD
Auranofin—Nausea—Phentermine—obesity	0.00106	0.00559	CcSEcCtD
Auranofin—Neuropathy peripheral—Bupropion—obesity	0.00106	0.00558	CcSEcCtD
Auranofin—Stomatitis—Bupropion—obesity	0.00105	0.00555	CcSEcCtD
Auranofin—Jaundice—Bupropion—obesity	0.00105	0.00555	CcSEcCtD
Auranofin—Conjunctivitis—Bupropion—obesity	0.00105	0.00553	CcSEcCtD
Auranofin—Eye disorder—Sibutramine—obesity	0.00104	0.00548	CcSEcCtD
Auranofin—Alopecia—Orlistat—obesity	0.00102	0.00535	CcSEcCtD
Auranofin—Diarrhoea—Cimetidine—obesity	0.00101	0.00533	CcSEcCtD
Auranofin—Vomiting—Diethylpropion—obesity	0.000989	0.00521	CcSEcCtD
Auranofin—Flatulence—Orlistat—obesity	0.000986	0.00519	CcSEcCtD
Auranofin—Alopecia—Sibutramine—obesity	0.000984	0.00518	CcSEcCtD
Auranofin—Rash—Diethylpropion—obesity	0.000981	0.00516	CcSEcCtD
Auranofin—Dysgeusia—Orlistat—obesity	0.00098	0.00516	CcSEcCtD
Auranofin—Dermatitis—Diethylpropion—obesity	0.00098	0.00516	CcSEcCtD
Auranofin—Flatulence—Sibutramine—obesity	0.000955	0.00503	CcSEcCtD
Auranofin—Dysgeusia—Sibutramine—obesity	0.000949	0.005	CcSEcCtD
Auranofin—Vomiting—Cimetidine—obesity	0.000941	0.00496	CcSEcCtD
Auranofin—Visual impairment—Bupropion—obesity	0.000935	0.00492	CcSEcCtD
Auranofin—Rash—Cimetidine—obesity	0.000933	0.00491	CcSEcCtD
Auranofin—Dermatitis—Cimetidine—obesity	0.000932	0.00491	CcSEcCtD
Auranofin—Nausea—Diethylpropion—obesity	0.000924	0.00487	CcSEcCtD
Auranofin—Angioedema—Orlistat—obesity	0.000915	0.00482	CcSEcCtD
Auranofin—Eye disorder—Bupropion—obesity	0.000907	0.00477	CcSEcCtD
Auranofin—Anaemia—Sibutramine—obesity	0.000895	0.00472	CcSEcCtD
Auranofin—Angioedema—Sibutramine—obesity	0.000885	0.00466	CcSEcCtD
Auranofin—Nausea—Cimetidine—obesity	0.000879	0.00463	CcSEcCtD
Auranofin—Leukopenia—Sibutramine—obesity	0.000867	0.00457	CcSEcCtD
Auranofin—Alopecia—Bupropion—obesity	0.000857	0.00452	CcSEcCtD
Auranofin—Flatulence—Bupropion—obesity	0.000832	0.00438	CcSEcCtD
Auranofin—Dysgeusia—Bupropion—obesity	0.000827	0.00436	CcSEcCtD
Auranofin—Anaemia—Bupropion—obesity	0.000781	0.00411	CcSEcCtD
Auranofin—Thrombocytopenia—Sibutramine—obesity	0.000774	0.00408	CcSEcCtD
Auranofin—Dysphagia—Topiramate—obesity	0.000772	0.00407	CcSEcCtD
Auranofin—Angioedema—Bupropion—obesity	0.000772	0.00406	CcSEcCtD
Auranofin—Eosinophilia—Topiramate—obesity	0.000765	0.00403	CcSEcCtD
Auranofin—Leukopenia—Bupropion—obesity	0.000756	0.00398	CcSEcCtD
Auranofin—Anorexia—Sibutramine—obesity	0.000754	0.00397	CcSEcCtD
Auranofin—Pancytopenia—Topiramate—obesity	0.000733	0.00386	CcSEcCtD
Auranofin—Neutropenia—Topiramate—obesity	0.000722	0.0038	CcSEcCtD
Auranofin—Dyspepsia—Orlistat—obesity	0.000719	0.00379	CcSEcCtD
Auranofin—Decreased appetite—Orlistat—obesity	0.00071	0.00374	CcSEcCtD
Auranofin—Weight decreased—Topiramate—obesity	0.000699	0.00368	CcSEcCtD
Auranofin—Dyspepsia—Sibutramine—obesity	0.000696	0.00367	CcSEcCtD
Auranofin—Decreased appetite—Sibutramine—obesity	0.000687	0.00362	CcSEcCtD
Auranofin—Constipation—Sibutramine—obesity	0.000676	0.00356	CcSEcCtD
Auranofin—Neuropathy peripheral—Topiramate—obesity	0.000675	0.00355	CcSEcCtD
Auranofin—Thrombocytopenia—Bupropion—obesity	0.000675	0.00355	CcSEcCtD
Auranofin—Stomatitis—Topiramate—obesity	0.000671	0.00353	CcSEcCtD
Auranofin—Conjunctivitis—Topiramate—obesity	0.000669	0.00352	CcSEcCtD
Auranofin—Gastrointestinal pain—Orlistat—obesity	0.000668	0.00352	CcSEcCtD
Auranofin—Anorexia—Bupropion—obesity	0.000657	0.00346	CcSEcCtD
Auranofin—Haematuria—Topiramate—obesity	0.000657	0.00346	CcSEcCtD
Auranofin—Urticaria—Orlistat—obesity	0.000649	0.00342	CcSEcCtD
Auranofin—Gastrointestinal pain—Sibutramine—obesity	0.000647	0.0034	CcSEcCtD
Auranofin—Abdominal pain—Orlistat—obesity	0.000646	0.0034	CcSEcCtD
Auranofin—Agranulocytosis—Topiramate—obesity	0.000643	0.00338	CcSEcCtD
Auranofin—Urticaria—Sibutramine—obesity	0.000628	0.00331	CcSEcCtD
Auranofin—Abdominal pain—Sibutramine—obesity	0.000625	0.00329	CcSEcCtD
Auranofin—Dyspepsia—Bupropion—obesity	0.000607	0.0032	CcSEcCtD
Auranofin—Decreased appetite—Bupropion—obesity	0.000599	0.00316	CcSEcCtD
Auranofin—Visual impairment—Topiramate—obesity	0.000596	0.00314	CcSEcCtD
Auranofin—Constipation—Bupropion—obesity	0.000589	0.0031	CcSEcCtD
Auranofin—Pruritus—Orlistat—obesity	0.000578	0.00304	CcSEcCtD
Auranofin—Eye disorder—Topiramate—obesity	0.000578	0.00304	CcSEcCtD
Auranofin—Gastrointestinal pain—Bupropion—obesity	0.000564	0.00297	CcSEcCtD
Auranofin—Pruritus—Sibutramine—obesity	0.000559	0.00295	CcSEcCtD
Auranofin—Diarrhoea—Orlistat—obesity	0.000559	0.00294	CcSEcCtD
Auranofin—Urticaria—Bupropion—obesity	0.000548	0.00288	CcSEcCtD
Auranofin—Alopecia—Topiramate—obesity	0.000546	0.00288	CcSEcCtD
Auranofin—Abdominal pain—Bupropion—obesity	0.000545	0.00287	CcSEcCtD
Auranofin—Diarrhoea—Sibutramine—obesity	0.000541	0.00285	CcSEcCtD
Auranofin—Flatulence—Topiramate—obesity	0.00053	0.00279	CcSEcCtD
Auranofin—Dysgeusia—Topiramate—obesity	0.000527	0.00278	CcSEcCtD
Auranofin—Vomiting—Orlistat—obesity	0.000519	0.00274	CcSEcCtD
Auranofin—Rash—Orlistat—obesity	0.000515	0.00271	CcSEcCtD
Auranofin—Dermatitis—Orlistat—obesity	0.000515	0.00271	CcSEcCtD
Auranofin—Vomiting—Sibutramine—obesity	0.000503	0.00265	CcSEcCtD
Auranofin—Rash—Sibutramine—obesity	0.000499	0.00263	CcSEcCtD
Auranofin—Dermatitis—Sibutramine—obesity	0.000498	0.00262	CcSEcCtD
Auranofin—Anaemia—Topiramate—obesity	0.000497	0.00262	CcSEcCtD
Auranofin—Pruritus—Bupropion—obesity	0.000488	0.00257	CcSEcCtD
Auranofin—Nausea—Orlistat—obesity	0.000485	0.00256	CcSEcCtD
Auranofin—Leukopenia—Topiramate—obesity	0.000482	0.00254	CcSEcCtD
Auranofin—Diarrhoea—Bupropion—obesity	0.000472	0.00248	CcSEcCtD
Auranofin—Nausea—Sibutramine—obesity	0.00047	0.00247	CcSEcCtD
Auranofin—Vomiting—Bupropion—obesity	0.000438	0.00231	CcSEcCtD
Auranofin—Rash—Bupropion—obesity	0.000435	0.00229	CcSEcCtD
Auranofin—Dermatitis—Bupropion—obesity	0.000434	0.00229	CcSEcCtD
Auranofin—Thrombocytopenia—Topiramate—obesity	0.00043	0.00226	CcSEcCtD
Auranofin—Anorexia—Topiramate—obesity	0.000419	0.0022	CcSEcCtD
Auranofin—Nausea—Bupropion—obesity	0.000409	0.00216	CcSEcCtD
Auranofin—Dyspepsia—Topiramate—obesity	0.000387	0.00204	CcSEcCtD
Auranofin—Decreased appetite—Topiramate—obesity	0.000382	0.00201	CcSEcCtD
Auranofin—Constipation—Topiramate—obesity	0.000376	0.00198	CcSEcCtD
Auranofin—Gastrointestinal pain—Topiramate—obesity	0.000359	0.00189	CcSEcCtD
Auranofin—Urticaria—Topiramate—obesity	0.000349	0.00184	CcSEcCtD
Auranofin—Abdominal pain—Topiramate—obesity	0.000347	0.00183	CcSEcCtD
Auranofin—Pruritus—Topiramate—obesity	0.000311	0.00164	CcSEcCtD
Auranofin—Diarrhoea—Topiramate—obesity	0.0003	0.00158	CcSEcCtD
Auranofin—Vomiting—Topiramate—obesity	0.000279	0.00147	CcSEcCtD
Auranofin—Rash—Topiramate—obesity	0.000277	0.00146	CcSEcCtD
Auranofin—Dermatitis—Topiramate—obesity	0.000277	0.00146	CcSEcCtD
Auranofin—Nausea—Topiramate—obesity	0.000261	0.00137	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—SLC2A4—obesity	3.64e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNB3—obesity	3.63e-05	0.000146	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—obesity	3.6e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TYK2—obesity	3.6e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CYCS—obesity	3.59e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CD—obesity	3.59e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARD—obesity	3.56e-05	0.000143	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—obesity	3.56e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCF2—obesity	3.56e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—obesity	3.54e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3R1—obesity	3.53e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNAS—obesity	3.53e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC27A1—obesity	3.49e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—obesity	3.48e-05	0.00014	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—NCOA1—obesity	3.47e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPY—obesity	3.47e-05	0.00014	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOB—obesity	3.46e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOC3—obesity	3.45e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IAPP—obesity	3.45e-05	0.000139	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLUL—obesity	3.42e-05	0.000138	CbGpPWpGaD
Auranofin—ALB—Metabolism—FABP4—obesity	3.42e-05	0.000138	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—BCL2—obesity	3.4e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3R1—obesity	3.39e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PLG—obesity	3.38e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—obesity	3.35e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CRH—obesity	3.35e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR1B—obesity	3.35e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SDC1—obesity	3.31e-05	0.000133	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	3.3e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—obesity	3.26e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CB—obesity	3.26e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C3—obesity	3.26e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOXO1—obesity	3.25e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism—ECHS1—obesity	3.25e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism—UCP2—obesity	3.25e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism—UCP3—obesity	3.25e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism—HSD11B1—obesity	3.25e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADH1B—obesity	3.19e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPS—obesity	3.17e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOB—obesity	3.15e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACSL1—obesity	3.14e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPAM—obesity	3.14e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARGC1B—obesity	3.14e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GNB3—obesity	3.14e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—obesity	3.14e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CD36—obesity	3.14e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—obesity	3.13e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—obesity	3.13e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—obesity	3.12e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DRD1—obesity	3.11e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2C—obesity	3.11e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD36—obesity	3.11e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—obesity	3.08e-05	0.000124	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—GNAS—obesity	3.06e-05	0.000123	CbGpPWpGaD
Auranofin—ALB—Metabolism—HADH—obesity	3.05e-05	0.000123	CbGpPWpGaD
Auranofin—ALB—Metabolism—PCK1—obesity	3.05e-05	0.000123	CbGpPWpGaD
Auranofin—ALB—Metabolism—FADS1—obesity	3.05e-05	0.000123	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCD—obesity	3.04e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NTRK2—obesity	3.03e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCD—obesity	3.02e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB1—obesity	3.01e-05	0.000121	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPL—obesity	3e-05	0.000121	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOB—obesity	2.99e-05	0.00012	CbGpPWpGaD
Auranofin—ALB—Metabolism—ACP5—obesity	2.97e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GHRL—obesity	2.95e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PARP1—obesity	2.95e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Immune System—C3—obesity	2.95e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—obesity	2.93e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DRD4—obesity	2.93e-05	0.000118	CbGpPWpGaD
Auranofin—ALB—Metabolism—G6PD—obesity	2.89e-05	0.000116	CbGpPWpGaD
Auranofin—ALB—Metabolism—SREBF2—obesity	2.86e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Metabolism—HK1—obesity	2.86e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CD36—obesity	2.86e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—obesity	2.85e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS2—obesity	2.8e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—obesity	2.8e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR1—obesity	2.79e-05	0.000112	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPA—obesity	2.76e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—obesity	2.75e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TCF7L2—obesity	2.74e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAV1—obesity	2.74e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOA1—obesity	2.73e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DRD2—obesity	2.73e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPIN1—obesity	2.7e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GCG—obesity	2.7e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTPN1—obesity	2.7e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—obesity	2.69e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—obesity	2.66e-05	0.000107	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARA—obesity	2.65e-05	0.000107	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA5—obesity	2.65e-05	0.000107	CbGpPWpGaD
Auranofin—ALB—Hemostasis—F2—obesity	2.61e-05	0.000105	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCB—obesity	2.61e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCB—obesity	2.59e-05	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—obesity	2.58e-05	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRL—obesity	2.57e-05	0.000104	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AGT—obesity	2.57e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BAD—obesity	2.56e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STK11—obesity	2.54e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—CLOCK—obesity	2.52e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC22A1—obesity	2.52e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PPARA—obesity	2.52e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—obesity	2.52e-05	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLG—obesity	2.51e-05	0.000101	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—obesity	2.5e-05	0.000101	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CAV1—obesity	2.5e-05	0.0001	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA1—obesity	2.49e-05	0.0001	CbGpPWpGaD
Auranofin—ALB—Metabolism—SULT2A1—obesity	2.46e-05	9.9e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLP1R—obesity	2.46e-05	9.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS1—obesity	2.45e-05	9.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO3—obesity	2.45e-05	9.85e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB2—obesity	2.44e-05	9.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—DPYD—obesity	2.42e-05	9.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOCS1—obesity	2.4e-05	9.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOCS3—obesity	2.38e-05	9.56e-05	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOA1—obesity	2.37e-05	9.53e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PRKAR2B—obesity	2.33e-05	9.38e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNB3—obesity	2.33e-05	9.36e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—DCN—obesity	2.31e-05	9.31e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—obesity	2.29e-05	9.2e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT2—obesity	2.28e-05	9.2e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—obesity	2.28e-05	9.19e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.27e-05	9.15e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT2—obesity	2.27e-05	9.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNAS—obesity	2.26e-05	9.11e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—obesity	2.26e-05	9.11e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CPT1A—obesity	2.25e-05	9.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOB—obesity	2.22e-05	8.93e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAMPT—obesity	2.21e-05	8.88e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—obesity	2.19e-05	8.84e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	2.19e-05	8.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—LIPC—obesity	2.19e-05	8.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCK—obesity	2.19e-05	8.83e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOC3—obesity	2.18e-05	8.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—obesity	2.18e-05	8.77e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—obesity	2.17e-05	8.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—obesity	2.17e-05	8.72e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	2.16e-05	8.71e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LPL—obesity	2.12e-05	8.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CETP—obesity	2.12e-05	8.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO1—obesity	2.1e-05	8.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RPS6KB1—obesity	2.1e-05	8.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TYK2—obesity	2.09e-05	8.43e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RHOA—obesity	2.09e-05	8.43e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SDC1—obesity	2.09e-05	8.42e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—obesity	2.07e-05	8.34e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3R1—obesity	2.07e-05	8.34e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C3—obesity	2.06e-05	8.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3R1—obesity	2.06e-05	8.28e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SCARB1—obesity	2.03e-05	8.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2e-05	8.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—obesity	1.99e-05	8e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2—obesity	1.98e-05	7.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SREBF1—obesity	1.97e-05	7.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—obesity	1.96e-05	7.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCD—obesity	1.95e-05	7.85e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GOT2—obesity	1.91e-05	7.7e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—obesity	1.91e-05	7.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HTR2A—obesity	1.91e-05	7.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—obesity	1.91e-05	7.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—C3—obesity	1.91e-05	7.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—obesity	1.9e-05	7.64e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—obesity	1.9e-05	7.64e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.89e-05	7.6e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—FASN—obesity	1.87e-05	7.54e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—BCHE—obesity	1.86e-05	7.51e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	1.85e-05	7.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS2—obesity	1.81e-05	7.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGT—obesity	1.81e-05	7.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2E1—obesity	1.8e-05	7.24e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NQO1—obesity	1.78e-05	7.16e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—obesity	1.77e-05	7.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—obesity	1.77e-05	7.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—obesity	1.76e-05	7.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CAV1—obesity	1.76e-05	7.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA1—obesity	1.75e-05	7.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—obesity	1.75e-05	7.04e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.74e-05	7.01e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.73e-05	6.95e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCG—obesity	1.71e-05	6.86e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SLC2A4—obesity	1.71e-05	6.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—obesity	1.69e-05	6.82e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYCS—obesity	1.68e-05	6.78e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—F2—obesity	1.67e-05	6.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCB—obesity	1.67e-05	6.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BAD—obesity	1.65e-05	6.66e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GGT1—obesity	1.65e-05	6.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GOT1—obesity	1.65e-05	6.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOA1—obesity	1.63e-05	6.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—obesity	1.62e-05	6.53e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—obesity	1.6e-05	6.46e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—STK11—obesity	1.6e-05	6.45e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP19A1—obesity	1.6e-05	6.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—obesity	1.6e-05	6.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS1—obesity	1.58e-05	6.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—obesity	1.56e-05	6.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—obesity	1.52e-05	6.14e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INS—obesity	1.52e-05	6.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—obesity	1.49e-05	6e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—COMT—obesity	1.49e-05	6e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARGC1A—obesity	1.47e-05	5.92e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNB3—obesity	1.47e-05	5.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—obesity	1.47e-05	5.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—obesity	1.47e-05	5.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT2—obesity	1.47e-05	5.9e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—obesity	1.46e-05	5.89e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNAS—obesity	1.43e-05	5.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—obesity	1.41e-05	5.67e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOB—obesity	1.4e-05	5.64e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—obesity	1.39e-05	5.61e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—obesity	1.37e-05	5.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TYK2—obesity	1.35e-05	5.45e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RHOA—obesity	1.34e-05	5.41e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPL—obesity	1.34e-05	5.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3R1—obesity	1.33e-05	5.35e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—obesity	1.33e-05	5.35e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—obesity	1.31e-05	5.26e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD36—obesity	1.27e-05	5.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—obesity	1.23e-05	4.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—obesity	1.23e-05	4.94e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—obesity	1.2e-05	4.85e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARA—obesity	1.18e-05	4.76e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—obesity	1.17e-05	4.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—obesity	1.16e-05	4.66e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AGT—obesity	1.14e-05	4.61e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—obesity	1.12e-05	4.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAV1—obesity	1.11e-05	4.47e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA1—obesity	1.11e-05	4.46e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—obesity	1.07e-05	4.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.06e-05	4.27e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—obesity	1.04e-05	4.18e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—obesity	1.02e-05	4.12e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—obesity	1.01e-05	4.07e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—obesity	9.77e-06	3.93e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—obesity	9.64e-06	3.88e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—INS—obesity	9.58e-06	3.86e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—obesity	9.53e-06	3.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—obesity	9.48e-06	3.82e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—obesity	9.45e-06	3.8e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—obesity	8.9e-06	3.58e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—obesity	8.81e-06	3.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—obesity	8.79e-06	3.54e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—obesity	8.4e-06	3.38e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3R1—obesity	8.4e-06	3.38e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—obesity	7.76e-06	3.12e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—obesity	7.69e-06	3.09e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—obesity	7.48e-06	3.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—obesity	6.62e-06	2.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—obesity	6.11e-06	2.46e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—obesity	4.73e-06	1.9e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—obesity	3.86e-06	1.55e-05	CbGpPWpGaD
